Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220014243 220014713 0 0 Curative (C) 2015-02-05 2015-02-05 AML16 DA 3+10 N N 220032991 AML16 TRIAL
220014244 220008778 1.8 8.5 Not known (9) null 2018-01-16 Cyclophosphamide+Fludara+TBI Allo Y N 220032995 CYCLOPHOSPHAMIDE + FLUDARABINE
220014245 220008779 1.77 67.8 Adjuvant (A) 2014-08-09 2014-08-20 CYCLOPHOSPHAMIDE N N 220032996 CYCLOPHOSPHAMIDE
220014246 220014714 1.72 99.2 Curative (C) 2016-05-27 2016-07-13 CYCLOPHOSPHAMIDE + FLUDARABINE N N 220032996 CYCLOPHOSPHAMIDE + FLUDARABINE
220014247 220008781 1.58 79.4 Palliative (P) 2016-04-03 2016-04-14 BOSUTINIB N N 220033003 BOSUTINIB
220014248 220008781 1.55 83.8 Palliative (P) 2017-10-05 2017-10-11 CYCLOPHOSPHAMIDE + FLUDARABINE 2 N 220033003 CYCLOPHOSPHAMIDE + FLUDARABINE
220014249 220008781 1.73 12.4 Not known (9) 2013-05-24 2013-05-26 Triple / Double Intrathecal Therapy N N 220033003 TRIPLE INTRATHECAL
220014250 220008782 1.5 null Curative (C) null 2014-02-02 Cyclophosphamide TBI Allograft null null 220033010 CYCLOPHOSPHAMIDE
220014251 220008785 1.69 0 Adjuvant (A) 2017-02-21 2017-02-21 AML16 DA 3+8 N N 220033011 AML16 TRIAL
220014252 220008786 null 113.8 Not known (9) 2013-07-27 2013-07-29 Methotrexate intrathecal N N 220033023 METHOTREXATE INTRATHECAL
220014253 220008787 0 71.6 Curative (C) 2015-10-08 2015-11-18 ADE 10+3+5 2 N 220033026 ADE
220014254 220014717 1.61 80.9 Disease modification (D) 2015-01-24 2015-01-30 Idarubicin+Tretinoin Spanish Crse1 02 N 220033029 IDARUBICIN + TRETINOIN
220014255 220014717 1.71 null Palliative (P) 2015-11-24 2015-11-27 IDARUBICIN + TRETINOIN N N 220033029 IDARUBICIN + TRETINOIN
220014256 220014717 1.65 81.2 Palliative (P) 2017-07-09 2017-10-27 Cyclophosphamide TBI Allograft N N 220033029 CYCLOPHOSPHAMIDE
220014257 220008788 1.66 75 Curative (C) 2017-01-02 2017-02-18 BOSUTINIB 2 N 220033036 BOSUTINIB
220014258 220008789 1.68 84 Palliative (P) 2013-06-16 2013-06-18 FLAG N N 220033039 FLAG
220014259 220014719 1.77 83.7 null 2016-03-22 2016-04-30 Cyclophosphamide+Fludara+TBI Allo N N 220033040 CYCLOPHOSPHAMIDE + FLUDARABINE
220014260 220014719 1.57 106 Not known (9) null 2014-12-31 Idarubicin+Tretinoin Spanish Crse2 N N 220033040 IDARUBICIN + TRETINOIN
220014261 220019898 1.69 60.3 Curative (C) null 2015-09-22 RUXOLITINIB N N 220033041 RUXOLITINIB
220014262 220008792 1.63 57.4 Disease modification (D) 2016-08-15 2016-12-08 BOSUTINIB N N 220033055 BOSUTINIB
220014263 220008793 1.57 45.6 Not known (9) 2013-10-13 2013-10-24 Cyclophosphamide+Fludara+TBI Allo 2 Y 220033060 CYCLOPHOSPHAMIDE + FLUDARABINE
220014264 220008793 null null Palliative (P) 2017-03-09 2017-03-12 Idarubicin+Tretinoin Spanish Crse1 null null 220033060 IDARUBICIN + TRETINOIN
220014265 220008793 1.64 71 Disease modification (D) 2015-06-15 2015-06-26 AML Int Guide ADE 10+3+5 (1) 2 null 220033060 ADE
220014266 220008795 1.86 92.6 Curative (C) 2013-01-09 2014-03-29 RUXOLITINIB 02 N 220033075 RUXOLITINIB
220014267 220018043 1.75 null Palliative (P) 2013-11-10 2013-11-17 Idarubicin+Tretinoin Spanish Crse2 N N 220033078 IDARUBICIN + TRETINOIN
220014268 220018043 1.76 null Palliative (P) 2013-09-27 2013-09-27 RUXOLITINIB 2 N 220033078 RUXOLITINIB
220014269 220008796 1.65 98.4 Disease modification (D) null 2016-03-04 Triple / Double Intrathecal Therapy N null 220033081 TRIPLE INTRATHECAL
220014271 220008799 1.56 65 null 2014-02-13 2014-07-15 ATG + Busulfan + Fludarabine Y N 220033087 ATG + BUSULFAN + FLUDARABINE
220014272 220008801 1.28 60 Curative (C) 2015-12-10 2016-02-10 RUXOLITINIB 02 N 220033090 RUXOLITINIB
220014273 220008801 null null 3 2014-02-22 2014-02-26 AML16 Low Dose Cytarabine N N 220033090 AML16 TRIAL
220014275 220008806 1.65 null Curative (C) 2016-06-03 2016-09-28 IDARUBICIN + TRETINOIN 02 null 220033114 IDARUBICIN + TRETINOIN
220014276 220008808 1.88 85.2 Curative (C) 2012-10-28 2013-12-02 FLAG 02 N 220033116 FLAG
220014277 220008810 1.55 69.4 Disease modification (D) 2013-06-03 2013-08-03 CYCLOPHOSPHAMIDE + FLUDARABINE N N 220033117 CYCLOPHOSPHAMIDE + FLUDARABINE
220014278 220008812 1.61 94 null 2016-07-12 2017-09-23 RUXOLITINIB N N 220033121 RUXOLITINIB
220014279 220008813 1.72 81.4 Palliative (P) 2016-10-02 2016-10-02 Cyclophosphamide TBI Allograft 2 N 220033122 CYCLOPHOSPHAMIDE
220014280 220008815 null null Disease modification (D) null 2016-07-10 Cyclophosphamide TBI Allograft N Y 220033123 CYCLOPHOSPHAMIDE
220014281 220008816 null null Curative (C) 2014-06-17 2014-06-19 CYCLOPHOSPHAMIDE 2 N 220033123 CYCLOPHOSPHAMIDE
220014282 220008816 1.08 20.5 Curative (C) null 2013-08-05 Cyclophosphamide+Fludara+TBI Allo null null 220033123 CYCLOPHOSPHAMIDE + FLUDARABINE
220014283 220008817 1.41 55.8 null 2017-05-15 2017-05-15 Triple / Double Intrathecal Therapy N null 220033132 TRIPLE INTRATHECAL
220014284 220008819 1.9 52.2 Curative (C) 2014-01-20 2014-02-17 ATG + Busulfan + Fludarabine 02 N 220033133 ATG + BUSULFAN + FLUDARABINE
220014285 220008819 1.58 null Disease modification (D) 2017-11-30 2017-11-30 BOSUTINIB N N 220033133 BOSUTINIB
220014286 220008820 1.56 23.6 Curative (C) 2016-01-15 2016-02-05 BOSUTINIB Y N 220033138 BOSUTINIB
220014287 220008821 null null Curative (C) 2015-06-15 2015-09-02 BOSUTINIB 2 N 220033144 BOSUTINIB
220014288 220008822 1.6 55 null 2014-09-19 2014-11-01 RUXOLITINIB 02 null 220033147 RUXOLITINIB
220014291 220014732 null 0 Disease modification (D) null 2017-04-08 IDARUBICIN + TRETINOIN 02 N 220033151 IDARUBICIN + TRETINOIN
220014292 220008829 null 78.8 Curative (C) 2016-07-10 2016-07-10 Methotrexate intrathecal N N 220033159 METHOTREXATE INTRATHECAL
220014293 220014733 1.3 63.9 null 2017-11-28 2017-12-05 CYCLOPHOSPHAMIDE + FLUDARABINE N null 220033159 CYCLOPHOSPHAMIDE + FLUDARABINE
220014294 220014733 1.8 null Palliative (P) 2014-07-19 2015-10-13 ATG + Busulfan + Fludarabine 02 Y 220033159 ATG + BUSULFAN + FLUDARABINE
220014295 220008830 1.77 70.9 null 2013-10-05 2014-05-03 Idarubicin+Tretinoin Spanish Crse1 Y N 220033173 IDARUBICIN + TRETINOIN
220014296 220008832 1.6 64 Curative (C) 2018-02-26 2018-03-04 PACLITAXEL N N 220033178 PACLITAXEL